Showing 2321-2330 of 6036 results for "".
- Bruder Announces Eyeleve Contact Lens Compresshttps://modernod.com/news/bruder-announces-eyeleve-contact-lens-compress/2479603/Bruder Healthcare announces the immediate availability of Eyeleve, a compress clinically proven to increase comfortable contact lens wear time by up to 3 hours daily. The Eyeleve Contact Lens Compress delivers consistent, therapeutic moist heat that alleviates symptoms of meibomian gland d
- CooperVision Acquires Blanchard Contact Lenses, Expanding Presence in Specialty Segmenthttps://modernod.com/news/coopervision-acquires-blanchard-contact-lenses-expanding-presence-in-specialty-segment/2476206/CooperVision has acquired Blanchard Contact Lenses, a maker of scleral lenses. Terms of the deal were not disclosed. Blanchard, with its network of distributors, operates in North America, Europe (including Scandinavia), Central America, and South America. Its recently introduced On
- Exonate Closes £1.5 Million Fundraising Accelerate Development Eye Drop Treatment for Retinal Neovascular Diseaseshttps://modernod.com/news/exonate-closes-1-5-million-fundraising-accelerate-development-eye-drop-treatment-for-retinal-neovascular-diseases/2476222/Exonate announces the successful closing of its fourth financing round, raising £1.5 million. The funds raised will be used to accelerate the development of Exonate’s lead product, an eye drop for the treatment of retinal neovascular diseases. The company continues to make substantial progress an
- ProQR Announces Publication of QR-110 Data for Leber’s Congenital Amaurosis 10https://modernod.com/news/proqr-announces-publication-of-qr-110-data-for-lebers-congenital-amaurosis-10/2479608/ProQR Therapeutics announced the publication of a peer-reviewed manuscript describing the previously announced interim results of a clinical trial of QR-110 for the treatment of Leber’s congenital amaurosis 10 (LCA10) in the journal
- FDA Clears First Daily Disposable Silicone Hydrogel Contact Lens Coated with Modified Formula of Tangible Hydra-PEGhttps://modernod.com/news/fda-clears-first-daily-disposable-silicone-hydrogel-contact-lens-coated-with-modified-formula-of-tangible-hydra-peg/2479611/Tangible Science announced that the FDA has cleared the first daily disposable silicone hydrogel contact lens coated with a modified formula of Tangible Hydra-PEG. Tangible Hydra-PEG is an innovative coating applied to custom contact lenses to improve lens wettability and deposit resistanc
- The Number of Optometric Practices Offering neurolens Contoured Prism Lenses More Than Quadrupled in 2018https://modernod.com/news/the-number-of-optometric-practices-offering-neurolens-contoured-prism-lenses-more-than-quadrupled-in-2018/2479617/Costa Mesa, California-based neurolens announced that adoption of their prescription lenses has grown among US optometric (OD) practices and by year end, 31 states will carry the company’s neurolenses and the neurolens measurement device. neurolenses are the first and only prescripti
- Federal Trade Commission Penalizes Online Sellers for Violating Contact Lens Rule, Bans Them from Selling Lenses in Futurehttps://modernod.com/news/federal-trade-commission-penalizes-online-sellers-for-violating-contact-lens-rule-bans-them-from-selling-lenses-in-future/2476152/The Healthcare Alliance for Patient Safety released a statement following yesterday’s announcement from the Federal Trade Commission (FTC)
- Alcon Launches Alcon Retina Fellows Institute to Support Future Leaders of Ophthalmologyhttps://modernod.com/news/alcon-launches-alcon-retina-fellows-institute-to-support-future-leaders-of-ophthalmology/2479630/Alcon announced it is expanding its support of eye care professionals through the launch of a one-of-a-kind training opportunity, the Alcon Retina Fellows Institute. The unique educational offering supports retina fellows during a weekend-long training at the Alcon Experience Center in Fort Worth
- AcuFocus Receives IDE Approval from the FDA to Begin Clinical Study of the IC-8 Lenshttps://modernod.com/news/acufocus-receives-ide-approval-from-the-fda-to-begin-clinical-study-of-the-ic-8-lens/2479646/AcuFocus announced that it has received approval for an investigational device exemption (IDE) from the FDA to conduct a pivotal study of the company’s IC-8 small aperture IOL for patients with cataracts. The AcuFocus IC-8 IOL is a clear monofocal lens with an embedded mini-ring or pinhole
- Verily, Alcon, Halt Project to Create a Glucose-Measuring Contact Lens; Other Eye-Monitoring Projects Continuehttps://modernod.com/news/verily-alcon-halt-work-on-glucose-sensing-smart-contact-lens/2479656/Google’s life sciences company Verily and Alcon have decided to halt their work on a smart contact lens to measure glucose levels in users with diabetes. In a blog post, Verily chief technical o